Overall, these cells showed reduced histologic tumor grade, EMT, and metastatic potential, concomitant with lessened immune cell activation, recruitment, and immunocompromised tumor background, with special regard to these features in the CD33+/11b+MDSCs. Here, CD33 is linked to neoplasm.